Skip to content
Friday 28 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 12 August 2013 10:58 am

Bribery may be common practice for drugs firms in China

By: Chris Harlow

Add as a preferred source on Google

Five drugs salesmen working for foreign companies operating in China have told the BBC their firms paid bribes to increase sales of products.

None wanted to be identified and the BBC didn’t say which firms were involved.

One said his company has paid around $1,000 to get its product back on the shelves at one hospital after its removal proved "an embarrassment" for him and his company. Following normal procedures would have "cost a lot of money and energy" he said. "We looked for a quick way."

The revalations follow allegations made last month that drugs giant GlaxoSmithKline trained its staff to build relationships with doctors by offering money and favours.

China’s official news agency Xinhua has said previously it is likely that more foreign and local pharmaceutical firms would be implicated in the corruption scandal, and the Chinese government is attempting to clamp down.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Morning Wire Content

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • Whey and weight-loss drugs to eat into Applied Nutrition profit

    Retail
    Woman lifting dumbbells with a trainer in a busy gym, promoting fitness and health
  • The European fintech American dream is being called into question

    Fintech
    Wise logo with downward trending stock chart, highlighting fintechs share decline amid Belgium fraud investigation
  • Jenrick pledges reform for small businesses

    Politics
    Robert Jenrick speaking at a podium with BRITISH WORKERS FIRST displayed, gesturing with his right hand.
  • ‘Absurd’: Government seeks quantum tech chief – no experience necessary

    Tech
    Advanced quantum computer with intricate circuits and glowing interface, illustrating cutting-edge technology innovations
  • Investors risk losing life savings with unregulated services, watchdog warns

    Regulation
    The FCA has introduced new proposals to close the financial advice gap.
  • The BBC shouldn’t push Londoners to accept antisocial phone behaviour 

    Opinion
    Passengers inside a graffiti-covered London Underground train car, some looking at phones, others observing the interior.
  • BBC to broadcast Alexis Ohanian co-founded all-female athletics series Athlos

    Sport Business
    Keely Hodgkinson waves to the crowd at a track and field event, wearing a purple and black athletic top.
  • Shareholder backlash pushes up low-ball London takeover bids

    Markets
    Over 100 major London-listed companies, including Fevertree Drinks and YouGov, have written to the Chancellor warning that the uncertainty surrounding the future of a key tax relief tied to London’s junior stock market is battering investor confidence. 
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook